Govt Mulls Norms For QR Code On Cosmetics, Apparel Brands To Curb Counterfeits

New Delhi: India is looking to lay down norms to counter the menace of counterfeit products mimicking the names and labels of brands of garments, apparel and cosmetics. The representatives from garments, apparel and cosmetics’ industries stated that they’re ready to share available data on counterfeit products to aid better policymaking by the government, sources told CNBC-TV18.

These entities met with Consumer Affairs Secretary Rohit Kumar Singh and discussed checking the sale of fake or counterfeit brands of apparel and cosmetics. The government is mulling guidelines to install QR codes on branded apparel and cosmetics to ease identification by users, as per sources. The proposed guidelines also aim to cover cosmetics sold via social media posts or reels.
Sources indicated that the government is mulling guidelines to install QR codes on branded apparel and cosmetics to ease identification by users. The proposed guidelines also aim to cover cosmetics sold via social media posts or reels.
A joint report issued by Credit Rating Information Services of India Limited (CRISIL) and the Authentication Solution Providers Association (ASPA) in January 2024 pointed out that 25% to 30% of all products sold in India were spurious. The report termed counterfeiting the most prevalent in the apparel and fast-moving consumer goods (FMCG) sectors.
The report claims 31% counterfeit products among apparel, followed by 28% in the FMCG segment, 25% in automotives, 20% in pharmaceuticals, 17% in consumer durables and 16% in agrochemicals.
The report covered 12 Indian cities: Jalandhar, Delhi, Agra, Jaipur, Patna, Indore, Ahmedabad, Kolkata, Mumbai, Hyderabad, Bangalore and Chennai. It also contended that 31% of consumers willingly bought spurious products, while 27% of consumers were unaware of having bought counterfeit products.

Related Posts

  • Pharma
  • July 26, 2024
  • 126 views
US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Maryland: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and…

  • Pharma
  • July 26, 2024
  • 125 views
Indian National Charged With Selling Counterfeit Cancer Drugs

HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Indian National Charged With Selling Counterfeit Cancer Drugs

Indian National Charged With Selling Counterfeit Cancer Drugs

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

BIS Sanctioned 82 Medical Device Projects To Develop Standards

BIS Sanctioned 82 Medical Device Projects To Develop Standards

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD